Is TVTX or UPC more undervalued in 2026?

CirclFi compares Travere Therapeutics, Inc. (TVTX) and Universe Pharmaceuticals Inc (UPC) using 13 institutional-grade valuation models. TVTX has a Quality of Company score of 6.2/10 while UPC scores 1.5/10.

Which is a better buy — TVTX or UPC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TVTX and UPC valuations compare?

TVTX at $47.18 and UPC at $3.50 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TVTX vs UPC Valuation Comparison 2026 — Intrinsic Value Analysis

TVTX

Pharmaceutical Preparations

Travere Therapeutics, Inc.

Quality

6.2

out of 10

Value Trap

SAFE

Price

$47.18

Last close

Models

11/13

Active

UPC

Pharmaceutical Preparations

Universe Pharmaceuticals Inc

Quality

1.5

out of 10

Value Trap

SAFE

Price

$3.50

Last close

Models

4/13

Active

Model-by-Model Comparison

Model	Type	TVTX Fair Value	TVTX Upside	UPC Fair Value	UPC Upside
Bayesian DCF	Intrinsic	$11.48	-75.7%	$0.53	-84.7%
Earnings Power Value	Intrinsic	$13.84	-68.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$5.74	-87.8%	$9.06	+235.7%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TVTX vs UPC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TVTX vs UPC — Which Stock Is More Undervalued?

TVTX scores higher with a 6.2/10 quality rating vs UPC's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Travere Therapeutics, Inc. (TVTX) and Universe Pharmaceuticals Inc (UPC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TVTX currently trades at $47.18 with a QOC of 6.2/10, while UPC trades at $3.50 with a QOC of 1.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).